case_images: PMC8593254_01
case_images: Graphs showing the platelet count, ADAMTS13 activity, and the anti-ADAMTS13 antibody trend correlated with the administered therapies in our two cases.
case_images: fped-09-743206-g0001.jpg
case_images: PMC8593254_02_fped-09-743206-g0001.jpg
case_images: F1
case_images: Platelet count remained normal even when PEX and caplacizumab were discontinued (Figure 1).
case_images: PMC8593254_02
case_images: Graphs showing the platelet count, ADAMTS13 activity, and the anti-ADAMTS13 antibody trend correlated with the administered therapies in our two cases.
case_images: fped-09-743206-g0001.jpg
case_images: PMC8593254_02_fped-09-743206-g0001.jpg
case_images: F1
case_images: Platelet count remained normal even when PEX and caplacizumab were discontinued (Figure 1).